Assessing ProAssurance (PRA) Valuation As Shares Hold Steady And Growth Expectations Moderate
ProAssurance (PRA) has seen steady share prices and mixed long-term returns, prompting investors to question its valuation. Analysts see the company as modestly overvalued with a fair value of US$22.67, anticipating revenue contraction but improved profit margins in the coming years. The valuation narrative highlights a trade-off between slower revenue growth and richer margins, underpinned by potential risks from legal costs and competitive pricing.
PRA Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial overview of ProAssurance Corp (PRA), detailing its profitability margins and comparing it to competitors like SAFT and UVE. It highlights PRA's operating margin of 20.19%, net margin of 12.23%, and a Return on Equity of 3.99%. The company maintains a leading market position with a market capitalization of $1.26 billion.
JPMorgan Chase & Co. Purchases 58,382 Shares of ProAssurance Corporation $PRA
JPMorgan Chase & Co. increased its stake in ProAssurance Corporation (NYSE:PRA) by 58.7% in the third quarter, acquiring an additional 58,382 shares to own a total of 157,891 shares valued at $3.79 million. Other institutional investors also boosted their positions, with overall institutional ownership in ProAssurance now at 85.58%. ProAssurance recently reported strong earnings, beating analyst estimates for both EPS and revenue, though revenue saw a 7.1% year-over-year decline.
ProAssurance (NYSE:PRA) Stock Rating Lowered by Wall Street Zen
Wall Street Zen has downgraded ProAssurance (NYSE:PRA) from a "hold" to a "sell" rating, despite the company exceeding Q4 earnings and revenue estimates. While other analysts have rated PRA differently, the MarketBeat consensus remains "Hold" with a target price of $25.00. Institutional investors have significantly increased their stakes in the company, which specializes in professional liability coverage for healthcare providers.
PRA SEC Filings - Proassurance Cp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors to access ProAssurance Corporation's (Ticker: PRA) SEC filings, including 10-K, 10-Q, and 8-K forms. It details the company's financial condition, segment performance, governance, and recent material events, particularly concerning its pending merger with The Doctors Company. The platform offers AI-powered summaries, impact scoring, and sentiment analysis for these regulatory documents.
Precision Trading with Proassurance Corporation (PRA) Risk Zones
This article provides a detailed AI-driven analysis for Proassurance Corporation (NYSE: PRA), identifying neutral sentiment across all time horizons and suggesting a wait-and-see approach. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis also highlights an exceptional 4.1:1 risk-reward short setup.
Vanguard disaggregates ProAssurance holdings (NYSE: PRA) — 0 shares reported
Vanguard has filed an amended Schedule 13G/A for ProAssurance Corp (NYSE: PRA), reporting zero beneficial ownership of common stock. This change is due to an internal realignment within Vanguard, where certain subsidiaries now report their holdings separately, as per SEC Release No. 34-39538. The filing indicates that The Vanguard Group itself no longer holds voting or dispositive power over any ProAssurance shares.
ProAssurance stock hits 52-week high at $24.78
ProAssurance Corp. (PRA) stock has hit a new 52-week high of $24.78, reflecting a positive trend and a 6.39% total return over the past year. Despite achieving this milestone and showing profitability, InvestingPro analysis suggests the stock may be overvalued relative to its Fair Value. The insurance company's performance is driven by strategic initiatives and favorable market conditions, attracting strong investor confidence.
ProAssurance stock hits 52-week high at $24.78 By Investing.com
ProAssurance (PRA) stock reached a new 52-week high of $24.78, currently trading at $24.79 with a market capitalization of $1.27 billion. The company has shown a 6.39% total return over the past year and has been profitable, though InvestingPro analysis suggests it may be overvalued relative to its Fair Value. This milestone reflects strong investor confidence and strategic execution by the company.
ProAssurance Corporation (NYSE:PRA) Given Consensus Recommendation of "Hold" by Brokerages
Six brokerages have issued a "Hold" consensus rating for ProAssurance Corporation (NYSE:PRA), with an average 1-year price target of $25.00. The company recently reported strong quarterly earnings, significantly beating EPS and revenue estimates, although revenue was down year-over-year. ProAssurance is currently trading near its 1-year high with substantial institutional ownership.
Hudson Bay Capital Management LP Raises Stock Position in ProAssurance Corporation $PRA
Hudson Bay Capital Management LP significantly increased its stake in ProAssurance Corporation (NYSE:PRA) by 1,050.0% in the third quarter, acquiring an additional 525,000 shares to own 575,000 shares worth $13.79 million. Other hedge funds, including Qube Research & Technologies Ltd, Hsbc Holdings PLC, Alliancebernstein L.P., Man Group plc, and Magnetar Financial LLC, also modified their holdings, with institutional investors owning 85.58% of the company's stock. ProAssurance recently reported strong earnings, exceeding consensus estimates, and analysts currently have a "Hold" rating on the stock with a consensus target price of $25.00.
Magnetar Financial Increases Stake in ProAssurance
Magnetar Financial LLC has increased its stake in ProAssurance Corporation (NYSE:PRA) by 2.3% during the third quarter, acquiring an additional 69,365 shares. This expands their total holdings to 3,026,173 shares, valued at $72.6 million, representing approximately 5.89% of the insurance provider's stock. The move highlights continued institutional confidence in ProAssurance's long-term prospects.
Magnetar Financial LLC Purchases 69,365 Shares of ProAssurance Corporation $PRA
Magnetar Financial LLC increased its holdings in ProAssurance Corporation (NYSE:PRA) by 2.3% during the third quarter, acquiring an additional 69,365 shares to own a total of 3,026,173 shares valued at approximately $72.6 million. This investment now represents about 0.4% of Magnetar's portfolio, making ProAssurance its 17th largest holding. ProAssurance recently outperformed earnings estimates, reporting an EPS of $0.82 against an expected $0.22, with revenues of $269.6 million.
What ProAssurance (PRA)'s Profit Jump Amid Lower Revenue Means For Shareholders
ProAssurance (PRA) reported a significant net income increase in Q4 2025 despite lower revenue, suggesting improved underwriting and cost controls are positively impacting earnings quality. While full-year 2025 revenue and EPS were slightly softer, the recent quarterly performance strengthens the thesis that disciplined management can enhance profitability even with top-line pressure. Investors are advised to monitor potential risks like rising claims severity and legal costs, though the company's long-term forecasts project earnings growth despite a revenue decline.
ProAssurance Corp stock hits 52-week high at 24.7 USD
ProAssurance Corp (PRA) stock has reached a new 52-week high of $24.70 USD, reflecting a 57.31% increase over the past year. The company has a market capitalization of $1.27 billion and a P/E ratio of 24.9, indicating strong investor confidence. Despite a "GOOD" financial health score, InvestingPro data suggests the stock might be overvalued relative to its Fair Value.
ProAssurance Stock Hits New 52-Week High
ProAssurance Corporation (NYSE:PRA) reached a new 52-week high of $24.71, closing at $24.59. This performance indicates market optimism despite mixed analyst ratings from Wall Street Zen (Hold), Zacks Research (Strong-Buy), and Weiss Ratings (Hold), with an overall consensus rating of "Hold" and a $25.00 price target. Investors are closely monitoring the company's financial health and future analyst updates.
ProAssurance Corp stock hits 52-week high at 24.7 USD
ProAssurance Corp (PRA) has reached a new 52-week high of $24.70, reflecting significant investor confidence and a 57.31% increase in stock price over the past year. The company has a market capitalization of $1.27 billion and a P/E ratio of 24.9, but InvestingPro suggests it may be overvalued despite a "GOOD" financial health score. Additional insights and analysis for PRA and other equities are available through InvestingPro Tips and comprehensive research reports.
ProAssurance Corporation Liability Coverage Model Gains NYSE Composite Attention
ProAssurance (NYSE:PRA) specializes in providing professional liability insurance to healthcare professionals, including physicians and medical institutions, and its market activities are drawing attention on the NYSE Composite. The article highlights the company's role in the specialized insurance sector and its relevance within broader financial markets. It also mentions that underwriting is crucial for ProAssurance, as it helps evaluate risk based on medical specialty and practice environment.
ProAssurance (NYSE:PRA) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen has upgraded ProAssurance (NYSE:PRA) from a "sell" to a "hold" rating, contributing to a consensus "Hold" rating and a $25.00 price target from analysts. The insurance provider recently reported strong quarterly earnings of $0.82 EPS, significantly beating estimates, and revenues of $269.6 million, though revenue was down year-over-year. Institutional investors hold a substantial portion of the stock, with several increasing their positions.
ProAssurance (PRA) executive converts RSUs and withholds shares for taxes
Kevin Merrick Shook, President of a ProAssurance (PRA) subsidiary, converted several Restricted Share Units (RSUs) into common stock on February 25, 2026, and simultaneously disposed of 7,587 shares to cover tax obligations. After these transactions, he directly held 53,447 shares of ProAssurance common stock. The RSUs, issued under the 2014 Equity Incentive Compensation Plan, vest in one-third increments over three years and accelerate under specific conditions like death, disability, or a qualifying "Good Reason" termination, with the cash portion covering federal, state, and local taxes.
Assessing ProAssurance (PRA) Valuation After Strong One Year Shareholder Returns
ProAssurance (PRA) has drawn investor attention due to its substantial one-year shareholder return of nearly 59%. Despite this strong performance and trading close to analyst price targets, the company is assessed as "8.4% Overvalued" with a narrative fair value of $22.67 compared to its closing price of $24.56. This valuation is influenced by expected future profitability improvements from renewal premium increases and re-underwriting efforts, alongside risks such as persistent legal cost pressures.
ProAssurance (NYSE: PRA) executive exercises RSUs and withholds shares for taxes
ProAssurance Corporation executive Robert David Francis exercised Restricted Stock Units on February 25, 2026, receiving 3,226, 8,765, and 5,890 shares of common stock at $24.47 per share. To cover tax obligations, 7,711 shares were disposed of. After these transactions, Francis directly holds 31,196 common shares and various tranches of RSUs vesting through 2029 under the company’s equity incentive plans.
ProAssurance (PRA) HR chief exercises RSUs, withholds 5,917 shares for taxes
Noreen Dishart, Executive VP and Chief HR Officer of ProAssurance Corporation, exercised restricted stock units (RSUs) on February 25, 2026, converting 4,588, 5,987, and 3,101 RSUs into common shares at $24.47 per share. To cover tax obligations, 5,917 shares were withheld, leaving her with a direct holding of 27,740 ProAssurance common shares. This transaction is an equity compensation event and not an open-market sale.
ProAssurance Corporation (NYSE:PRA) Given Average Recommendation of "Reduce" by Analysts
Analysts have given ProAssurance Corporation (NYSE:PRA) a consensus "Reduce" recommendation, with one sell rating and five hold ratings. The average 1-year price target is $25.00. The company recently reported strong earnings of $0.82 EPS, significantly beating estimates, though revenue was down 7.1% year-over-year.
ProAssurance Surpasses Q4 Earnings Expectations as Costs Decrease
ProAssurance Corporation exceeded Q4 2025 earnings expectations with adjusted operating earnings of $0.82 per share, significantly above the Zacks Consensus Estimate of $0.22. This strong performance was driven by higher investment income and reduced expenses, despite a decrease in operating revenue and gross premiums written. The company also saw a substantial improvement in its combined ratio and net income.
ProAssurance Surpasses Q4 Earnings Expectations as Costs Decrease
ProAssurance Corporation reported better-than-expected Q4 2025 earnings of $0.82 per share, significantly exceeding the Zacks Consensus Estimate of $0.22, despite a decrease in operating revenue. This strong performance was attributed to higher investment income and reduced expenses, although partially offset by declining premiums in some segments. The company's net income soared by 106.4%, and its combined ratio improved substantially, leading to a Zacks Rank #1 (Strong Buy).
ProAssurance stock hits 52-week high at 24.66 USD
ProAssurance Corp's stock has reached a 52-week high of $24.66, marking a 51.7% total return over the past year. The insurance company, with a market cap of $1.27 billion and a P/E ratio of 37.23, is showing strong market presence and investor confidence. While currently trading near its peak, InvestingPro analysts suggest it may be overvalued based on their Fair Value analysis.
ProAssurance (PRA) Combined Ratios Above 100% Reinforce Cautious Underwriting Narratives
ProAssurance (PRA) reported fourth-quarter 2025 revenue of US$259.6 million and basic EPS of US$0.65, with combined ratios above 100% indicating higher underwriting costs than premium income. Despite these combined ratios and a modest 4.6% net profit margin, investment income has supported overall profitability, and the company has shown a five-year earnings growth of 22.2% annually. The stock's P/E ratio of 24.7x is above the US insurance industry average, reflecting market expectations for future earnings growth despite projected revenue declines.
ProAssurance Corp (NYSE:PRA) Beats Q4 Estimates on Strong Underwriting and Favorable Reserves
ProAssurance Corp (NYSE:PRA) exceeded Q4 2025 earnings and revenue estimates, driven by strong underwriting performance and significant favorable prior-year loss reserve development. The company reported $0.82 non-GAAP EPS on $269.6 million in revenue, surpassing analyst expectations. This positive performance occurred as the company progresses towards its acquisition by The Doctors Company, anticipated to close by June 30, 2026.
ProAssurance: Q4 Earnings Snapshot
ProAssurance Corp. (PRA) reported strong fourth-quarter earnings, exceeding Wall Street expectations. The medical professional liability insurer announced a profit of $33.4 million, or 64 cents per share, with adjusted earnings of 82 cents per share. Revenue for the quarter was $269.6 million, with adjusted revenue reaching $271.6 million, also surpassing analyst forecasts.
ProAssurance: Q4 Earnings Snapshot
ProAssurance Corp. (PRA) reported strong fourth-quarter earnings, exceeding Wall Street expectations. The medical professional liability insurer posted a profit of $33.4 million, or 64 cents per share, with adjusted earnings of 82 cents per share. Revenue for the period was $269.6 million, with adjusted revenue reaching $271.6 million, also surpassing analyst forecasts.
ProAssurance: Fourth Quarter Earnings Overview
ProAssurance Corp. announced strong financial results for the fourth quarter, reporting a net income of $33.4 million and adjusted earnings of 82 cents per share, significantly exceeding Wall Street estimates. The medical professional liability insurer generated $269.6 million in revenue, with adjusted revenue of $271.6 million also surpassing expectations. For the full year, the company posted a profit of $50.9 million on $1.09 billion in revenue.
PROASSURANCE ($PRA) Releases Q4 2025 Earnings
PROASSURANCE ($PRA) reported strong Q4 2025 earnings, with $0.82 per share, significantly surpassing analyst estimates of $0.26. The company also exceeded revenue expectations, bringing in $271.56 million against an estimated $212.49 million. Institutional investors showed mixed activity, with some major increases and decreases in holdings during the quarter.
ProAssurance: Q4 Earnings Snapshot
ProAssurance Corp. (PRA) surpassed Wall Street's expectations for its fourth-quarter earnings, reporting a profit of $33.4 million, or 82 cents per share adjusted, against an estimated 22 cents per share. The medical professional liability insurer also exceeded revenue forecasts, posting $269.6 million. For the full year, ProAssurance reported a profit of $50.9 million and revenue of $1.09 billion.
ProAssurance Corporation Q4 and Full-Year 2025 Financial Results
ProAssurance Corporation has announced its financial results for the fourth quarter and full year ending December 31, 2025, reporting a net income of $50.9 million for the full year and an operating income of $83.9 million. Key highlights include an 8.3% increase in consolidated net investment income and an improvement in the Non-GAAP combined ratio to 104.2% for the full year. The company also progressed with its strategic merger with The Doctors Company, expected to close by mid-2026.
ProAssurance (NYSE:PRA) Releases Quarterly Earnings Results, Beats Estimates By $0.60 EPS
ProAssurance (NYSE:PRA) announced its quarterly earnings, reporting an EPS of $0.82, significantly exceeding the consensus estimate of $0.22 by $0.60, with revenues of $269.64 million also surpassing expectations. Despite strong financial performance, including a 3.01% net margin and 4.78% ROE, the stock holds a "Reduce" consensus rating from Wall Street analysts with a target price of $25.00. Institutional investors hold approximately 85.6% of the company's shares.
ProAssurance Reports Results for Fourth Quarter and Full-Year 2025
ProAssurance Corporation reported strong financial results for the fourth quarter and full-year 2025, with significant increases in net income and operating income compared to the previous year. The company's Specialty P&C segment showed improved combined ratios, and the ongoing merger with The Doctors Company is progressing, awaiting final regulatory approvals. ProAssurance continues to focus on rate adequacy in challenging market conditions and achieved an 8% renewal premium increase for its Specialty P&C segment.
ProAssurance: Q4 Earnings Snapshot
ProAssurance Corp. reported strong fourth-quarter earnings, with profits of $33.4 million, or 64 cents per share. Adjusted earnings of 82 cents per share significantly exceeded Wall Street expectations of 22 cents per share. The medical professional liability insurer also surpassed revenue forecasts, posting adjusted revenue of $271.6 million.
Gardner Lewis Asset Management L P Invests $7.01 Million in ProAssurance Corporation $PRA
Gardner Lewis Asset Management L P has invested $7.01 million in ProAssurance Corporation (NYSE:PRA), acquiring a new stake of 292,070 shares. This investment represents approximately 1.7% of Gardner Lewis's portfolio and 0.57% of ProAssurance. Despite significant institutional ownership totaling about 85.58% and a market cap of $1.26 billion, analysts currently hold a "Reduce" rating on ProAssurance with an average price target of $25.00.
ProAssurance earnings in focus as Doctors merger nears close By Investing.com
ProAssurance Corporation is set to release its Q4 earnings, which could be its last as a standalone public company before its acquisition by The Doctors Company closes in the first half of 2026. Analysts expect improved earnings per share of $0.22, despite a projected revenue decline, as the company's stock trades near its 52-week high, supported by the $25.00 per share acquisition offer. Investors will be closely watching underwriting margins, expense management, and premium rate trends, along with any further updates on the acquisition during the earnings report.
ProAssurance earnings in focus as Doctors merger nears close By Investing.com
ProAssurance is set to release its Q4 earnings, which could be its last as a standalone public company before its acquisition by The Doctors Company closes. Analysts expect earnings of $0.22 per share and revenue of $221.6 million, with investors closely watching its ability to maintain profitability amidst declining revenue and rising medical malpractice insurance rates. The merger, which has received shareholder approval, is expected to close in the first half of 2026.
ProAssurance earnings in focus as Doctors merger nears close By Investing.com
ProAssurance is expected to report its fourth-quarter earnings, potentially its last as a standalone public company before its acquisition by The Doctors Company. Analysts anticipate earnings of $0.22 per share on $221.6 million in revenue, with improving profitability despite projected revenue decline. Investors will focus on underwriting margins, expense management, pricing power, and updates regarding the merger, which is expected to close in the first half of 2026.
ProAssurance (PRA) Expected to Announce Earnings on Monday
ProAssurance (NYSE: PRA) is slated to announce its Q4 2025 earnings before market open on Monday, February 23, 2026, with analysts anticipating earnings of $0.22 per share. The company's stock opened at $24.54, near its 12-month high, and has a market capitalization of $1.26 billion. Analyst sentiment is generally cautious, with a consensus "Reduce" rating and an average target price of $25.00.
Credit Industriel ET Commercial Sells 80,720 Shares of ProAssurance Corporation $PRA
Credit Industriel ET Commercial has reduced its stake in ProAssurance Corporation (NYSE:PRA) by 24.2%, selling 80,720 shares and now possessing 252,275 shares valued at approximately $6.05 million. Despite this, several other institutions significantly increased their positions, leading institutional investors to collectively own about 85.58% of ProAssurance. Analysts maintain a cautious outlook with a "Reduce" consensus rating and a $25.00 price target, while the stock trades near its 52-week high with a market cap of $1.26 billion.
ProAssurance stock hits 52-week high at 24.63 USD By Investing.com
ProAssurance (PRA) stock has reached a new 52-week high of $24.63, reflecting strong investor confidence and a 67.63% total return over the past year. Despite its premium valuation with a P/E ratio of 37.37 and weak gross profit margins, the company maintains strong liquidity. Investors are awaiting its earnings report on February 23 for future performance insights.
ProAssurance stock hits 52-week high at 24.63 USD By Investing.com
ProAssurance (PRA) stock has reached a new 52-week high of $24.63, reflecting strong investor confidence and a 67.63% total return over the past year. Despite trading slightly above its Fair Value with a P/E ratio of 37.37, the company maintains strong liquidity with a current ratio of 2.36, although it faces weak gross profit margins. Investors are looking ahead to the upcoming earnings report on February 23rd, which could influence future performance.
ProAssurance stock hits 52-week high at 24.63 USD
ProAssurance Corp's stock has reached a new 52-week high at 24.63 USD, reflecting a 67.63% total return over the past year. Despite trading slightly above its Fair Value with a P/E ratio of 37.37, the company exhibits low price volatility and strong liquidity. Investors are advised to watch for its upcoming earnings report on February 23 for potential impacts on future performance.
Alpine Associates Management Inc. Purchases 403,807 Shares of ProAssurance Corporation $PRA
Alpine Associates Management Inc. significantly increased its stake in ProAssurance Corporation (NYSE:PRA) by 73.6% in the third quarter, purchasing an additional 403,807 shares. This makes ProAssurance the fund's 18th largest position, accounting for 1.4% of its investment portfolio, valued at $22.852 million. Other institutional investors also adjusted their holdings in ProAssurance, while Wall Street analysts currently rate the stock with a consensus of "Reduce" and a price target of $25.00.
ProAssurance (NYSE:PRA) Stock Price Passes Above 200-Day Moving Average - Should You Sell?
ProAssurance (NYSE:PRA) stock recently traded above its 200-day moving average. Despite this, analysts have a "Reduce" consensus rating with a $25.00 price target. Institutional investors have increased their holdings, but the article questions whether investors should sell.
ProAssurance Corp stock hits 52-week high at 24.44 USD By Investing.com
ProAssurance Corp (PRA) stock has reached a new 52-week high of $24.44, representing a 64.43% increase over the past year. This achievement underscores the company's strong market position and investor confidence in the insurance industry. Despite weak gross profit margins, the stock exhibits low volatility and solid liquidity.
